TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Efficacy and Cost Analysis of Steroids in Treatment of Otitis Media With Effusion (OME) Compared to That of Combination of Antibiotic, Antihistaminic, and Nasal Decongestant
Brief Summary: We intend to study the cost of treatment, efficacy and adverse effects for Otitis media with effusion.


Options:
A: Arm Label: Triamcinolone acetonide; Type: ACTIVE_COMPARATOR; Interventions: Drug: Triamcinolone acetonide nasal spray | Arm Label: Placebo; Type: SHAM_COMPARATOR; Interventions: Drug: Placebo nasal spray | Intervention Type: DRUG; Name: Triamcinolone acetonide nasal spray; Assigned to Arm(s): Triamcinolone acetonide | Intervention Type: DRUG; Name: Placebo nasal spray; Assigned to Arm(s): Placebo
B: Arm Label: Ventilation tube treatment; Type: EXPERIMENTAL; Interventions: Device: Ventilation tube treatment | Arm Label: Conservative treatment; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Ventilation tube treatment; Assigned to Arm(s): Ventilation tube treatment
C: Arm Label: Wait and watch (Group D); Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Mometasone spray (Group B); Type: EXPERIMENTAL; Interventions: Drug: Mometasone 50 Mcg/Inh Nasal Spray | Arm Label: antibiotic + histaminic + oxymetazoline drops (Group A); Type: EXPERIMENTAL; Interventions: Drug: Antibiotics + Antihistamine (levocetirizine) + Nasal decongestants (Oxymetazoline 0.025%) | Arm Label: Oral steroid (Group C); Type: EXPERIMENTAL; Interventions: Drug: Steroid Drug (prednisolone) | Intervention Type: DRUG; Name: Mometasone 50 Mcg/Inh Nasal Spray; Assigned to Arm(s): Mometasone spray (Group B) | Intervention Type: DRUG; Name: Antibiotics + Antihistamine (levocetirizine) + Nasal decongestants (Oxymetazoline 0.025%); Assigned to Arm(s): antibiotic + histaminic + oxymetazoline drops (Group A) | Intervention Type: DRUG; Name: Steroid Drug (prednisolone); Assigned to Arm(s): Oral steroid (Group C)
D: Intervention Type: PROCEDURE; Name: Insertion of tympanostomy tubes; Assigned to Arm(s): N/A

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Efficacy and Cost Analysis of Steroids in Treatment of Otitis Media With Effusion (OME) Compared to That of Combination of Antibiotic, Antihistaminic, and Nasal Decongestant
Brief Summary: We intend to study the cost of treatment, efficacy and adverse effects for Otitis media with effusion.


Options:
A: Arm Label: Triamcinolone acetonide; Type: ACTIVE_COMPARATOR; Interventions: Drug: Triamcinolone acetonide nasal spray | Arm Label: Placebo; Type: SHAM_COMPARATOR; Interventions: Drug: Placebo nasal spray | Intervention Type: DRUG; Name: Triamcinolone acetonide nasal spray; Assigned to Arm(s): Triamcinolone acetonide | Intervention Type: DRUG; Name: Placebo nasal spray; Assigned to Arm(s): Placebo
B: Arm Label: Wait and watch (Group D); Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Mometasone spray (Group B); Type: EXPERIMENTAL; Interventions: Drug: Mometasone 50 Mcg/Inh Nasal Spray | Arm Label: antibiotic + histaminic + oxymetazoline drops (Group A); Type: EXPERIMENTAL; Interventions: Drug: Antibiotics + Antihistamine (levocetirizine) + Nasal decongestants (Oxymetazoline 0.025%) | Arm Label: Oral steroid (Group C); Type: EXPERIMENTAL; Interventions: Drug: Steroid Drug (prednisolone) | Intervention Type: DRUG; Name: Mometasone 50 Mcg/Inh Nasal Spray; Assigned to Arm(s): Mometasone spray (Group B) | Intervention Type: DRUG; Name: Antibiotics + Antihistamine (levocetirizine) + Nasal decongestants (Oxymetazoline 0.025%); Assigned to Arm(s): antibiotic + histaminic + oxymetazoline drops (Group A) | Intervention Type: DRUG; Name: Steroid Drug (prednisolone); Assigned to Arm(s): Oral steroid (Group C)
C: Arm Label: Montelukast; Type: EXPERIMENTAL; Interventions: Drug: Monteleukast | Arm Label: Mometasone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Mometasone | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Monteleukast; Assigned to Arm(s): Montelukast | Intervention Type: DRUG; Name: Mometasone; Assigned to Arm(s): Mometasone
D: Arm Label: Ventilation tube treatment; Type: EXPERIMENTAL; Interventions: Device: Ventilation tube treatment | Arm Label: Conservative treatment; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Ventilation tube treatment; Assigned to Arm(s): Ventilation tube treatment

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Efficacy and Cost Analysis of Steroids in Treatment of Otitis Media With Effusion (OME) Compared to That of Combination of Antibiotic, Antihistaminic, and Nasal Decongestant
Brief Summary: We intend to study the cost of treatment, efficacy and adverse effects for Otitis media with effusion.


Options:
A: Arm Label: Triamcinolone acetonide; Type: ACTIVE_COMPARATOR; Interventions: Drug: Triamcinolone acetonide nasal spray | Arm Label: Placebo; Type: SHAM_COMPARATOR; Interventions: Drug: Placebo nasal spray | Intervention Type: DRUG; Name: Triamcinolone acetonide nasal spray; Assigned to Arm(s): Triamcinolone acetonide | Intervention Type: DRUG; Name: Placebo nasal spray; Assigned to Arm(s): Placebo
B: Arm Label: Ventilation tube treatment; Type: EXPERIMENTAL; Interventions: Device: Ventilation tube treatment | Arm Label: Conservative treatment; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Ventilation tube treatment; Assigned to Arm(s): Ventilation tube treatment
C: Arm Label: Montelukast; Type: EXPERIMENTAL; Interventions: Drug: Monteleukast | Arm Label: Mometasone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Mometasone | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Monteleukast; Assigned to Arm(s): Montelukast | Intervention Type: DRUG; Name: Mometasone; Assigned to Arm(s): Mometasone
D: Arm Label: Wait and watch (Group D); Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Mometasone spray (Group B); Type: EXPERIMENTAL; Interventions: Drug: Mometasone 50 Mcg/Inh Nasal Spray | Arm Label: antibiotic + histaminic + oxymetazoline drops (Group A); Type: EXPERIMENTAL; Interventions: Drug: Antibiotics + Antihistamine (levocetirizine) + Nasal decongestants (Oxymetazoline 0.025%) | Arm Label: Oral steroid (Group C); Type: EXPERIMENTAL; Interventions: Drug: Steroid Drug (prednisolone) | Intervention Type: DRUG; Name: Mometasone 50 Mcg/Inh Nasal Spray; Assigned to Arm(s): Mometasone spray (Group B) | Intervention Type: DRUG; Name: Antibiotics + Antihistamine (levocetirizine) + Nasal decongestants (Oxymetazoline 0.025%); Assigned to Arm(s): antibiotic + histaminic + oxymetazoline drops (Group A) | Intervention Type: DRUG; Name: Steroid Drug (prednisolone); Assigned to Arm(s): Oral steroid (Group C)

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Efficacy and Cost Analysis of Steroids in Treatment of Otitis Media With Effusion (OME) Compared to That of Combination of Antibiotic, Antihistaminic, and Nasal Decongestant
Brief Summary: We intend to study the cost of treatment, efficacy and adverse effects for Otitis media with effusion.


Options:
A: Arm Label: Ventilation tube treatment; Type: EXPERIMENTAL; Interventions: Device: Ventilation tube treatment | Arm Label: Conservative treatment; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Ventilation tube treatment; Assigned to Arm(s): Ventilation tube treatment
B: Arm Label: Wait and watch (Group D); Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Mometasone spray (Group B); Type: EXPERIMENTAL; Interventions: Drug: Mometasone 50 Mcg/Inh Nasal Spray | Arm Label: antibiotic + histaminic + oxymetazoline drops (Group A); Type: EXPERIMENTAL; Interventions: Drug: Antibiotics + Antihistamine (levocetirizine) + Nasal decongestants (Oxymetazoline 0.025%) | Arm Label: Oral steroid (Group C); Type: EXPERIMENTAL; Interventions: Drug: Steroid Drug (prednisolone) | Intervention Type: DRUG; Name: Mometasone 50 Mcg/Inh Nasal Spray; Assigned to Arm(s): Mometasone spray (Group B) | Intervention Type: DRUG; Name: Antibiotics + Antihistamine (levocetirizine) + Nasal decongestants (Oxymetazoline 0.025%); Assigned to Arm(s): antibiotic + histaminic + oxymetazoline drops (Group A) | Intervention Type: DRUG; Name: Steroid Drug (prednisolone); Assigned to Arm(s): Oral steroid (Group C)
C: Intervention Type: PROCEDURE; Name: Insertion of tympanostomy tubes; Assigned to Arm(s): N/A
D: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Amoxycillin | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo equivalent to amoxycillin | Intervention Type: DRUG; Name: Amoxycillin; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Placebo equivalent to amoxycillin; Assigned to Arm(s): 2

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Efficacy and Cost Analysis of Steroids in Treatment of Otitis Media With Effusion (OME) Compared to That of Combination of Antibiotic, Antihistaminic, and Nasal Decongestant
Brief Summary: We intend to study the cost of treatment, efficacy and adverse effects for Otitis media with effusion.


Options:
A: Intervention Type: PROCEDURE; Name: adenoidectomy and tymapanostomy; Assigned to Arm(s): N/A
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Amoxycillin | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo equivalent to amoxycillin | Intervention Type: DRUG; Name: Amoxycillin; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Placebo equivalent to amoxycillin; Assigned to Arm(s): 2
C: Arm Label: Wait and watch (Group D); Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Mometasone spray (Group B); Type: EXPERIMENTAL; Interventions: Drug: Mometasone 50 Mcg/Inh Nasal Spray | Arm Label: antibiotic + histaminic + oxymetazoline drops (Group A); Type: EXPERIMENTAL; Interventions: Drug: Antibiotics + Antihistamine (levocetirizine) + Nasal decongestants (Oxymetazoline 0.025%) | Arm Label: Oral steroid (Group C); Type: EXPERIMENTAL; Interventions: Drug: Steroid Drug (prednisolone) | Intervention Type: DRUG; Name: Mometasone 50 Mcg/Inh Nasal Spray; Assigned to Arm(s): Mometasone spray (Group B) | Intervention Type: DRUG; Name: Antibiotics + Antihistamine (levocetirizine) + Nasal decongestants (Oxymetazoline 0.025%); Assigned to Arm(s): antibiotic + histaminic + oxymetazoline drops (Group A) | Intervention Type: DRUG; Name: Steroid Drug (prednisolone); Assigned to Arm(s): Oral steroid (Group C)
D: Intervention Type: PROCEDURE; Name: Insertion of tympanostomy tubes; Assigned to Arm(s): N/A

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Communication App to Manage Symptoms and Improve Adjuvant Endocrine Therapy Adherence
Brief Summary: This study will test the use of a web-enabled app that is integrated directly with patients' electronic health records, with and without tailored feedback. The app-based intervention is designed to improve patient-provider communication outside of clinic visits, resulting in improved symptom management and adjuvant endocrine therapy adherence among diverse patients with hormone receptor-positive breast cancer. The researchers will evaluate the impact of the intervention on a comprehensive set of outcomes, including rigorous measures of long-term adherence, quality of life, and costs.


Options:
A: Arm Label: FLARE Intervention Group; Type: OTHER; Interventions: Other: FLARE Intervention Group | Arm Label: Standard of Care (SOC) Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: FLARE Intervention Group; Assigned to Arm(s): FLARE Intervention Group
B: Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: THRIVE App; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: THRIVE App | Arm Label: THRIVE App+Feedback; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: THRIVE App, Behavioral: Tailored Feedback Messages | Intervention Type: BEHAVIORAL; Name: THRIVE App; Assigned to Arm(s): THRIVE App, THRIVE App+Feedback | Intervention Type: BEHAVIORAL; Name: Tailored Feedback Messages; Assigned to Arm(s): THRIVE App+Feedback
C: Arm Label: Implementation intervention; Type: EXPERIMENTAL; Interventions: Other: Implementation intervention | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Implementation intervention; Assigned to Arm(s): Implementation intervention
D: Arm Label: PRO-based follow-up; Type: EXPERIMENTAL; Interventions: Behavioral: PRO-based follow-up | Arm Label: PRO-based telephone consultations; Type: EXPERIMENTAL; Interventions: Behavioral: PRO-based telephone consultation | Arm Label: Usual outpatient follow-up visits; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: PRO-based follow-up; Assigned to Arm(s): PRO-based follow-up | Intervention Type: BEHAVIORAL; Name: PRO-based telephone consultation; Assigned to Arm(s): PRO-based telephone consultations

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effects of an In-school Physical Activity Intervention on Adolescents' Brain Structure and Function ('Fit to Study' Brain Imaging Sub-study)
Brief Summary: Physical activity has shown beneficial effects for cognitive and brain health, suggesting it may provide a highly scalable intervention to improve academic achievement. This project is part of a large-scale randomised controlled trial called Fit to Study (ClinicalTrials.gov ID: NCT03286725). The main Fit to Study trial aims to test the effect of a school-based physical activity intervention on academic performance (as well as cognition and physical measures) across Year 8 pupils in 100 secondary schools. The current study - the Fit to Study - Brain imaging sub-study - will target a sub-sample of participants in the large-scale trial, in order to test pre- to post intervention changes in hippocampal volume, as well as cognitive performance, mental health and brain organisation. We hypothesise that the intervention will change anterior hippocampal volume of Year-8 pupils, as well as mental health, cognitive performance, and more generally, brain structure and function. We further hypothesise that changes in brain organisation (e.g. hippocampal volume) may mediate changes in cognitive performance and mental health.


Options:
A: Arm Label: Usual Practice; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Action Schools! BC; Type: EXPERIMENTAL; Interventions: Behavioral: Action Schools! BC | Intervention Type: BEHAVIORAL; Name: Action Schools! BC; Assigned to Arm(s): Action Schools! BC
B: Arm Label: Program SI! for Elementary 6 levels; Type: EXPERIMENTAL; Interventions: Behavioral: PSIE13, Behavioral: PSIE46 | Arm Label: Normal curriculum; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Program SI! for Elementary first levels; Type: EXPERIMENTAL; Interventions: Behavioral: PSIE13 | Arm Label: Program SI! for Elementary last levels; Type: EXPERIMENTAL; Interventions: Behavioral: PSIE46 | Intervention Type: BEHAVIORAL; Name: PSIE13; Assigned to Arm(s): Program SI! for Elementary 6 levels, Program SI! for Elementary first levels | Intervention Type: BEHAVIORAL; Name: PSIE46; Assigned to Arm(s): Program SI! for Elementary 6 levels, Program SI! for Elementary last levels
C: Arm Label: "PE as Usual" Control Group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention Group; Type: EXPERIMENTAL; Interventions: Behavioral: Physical Education (PE) programme | Intervention Type: BEHAVIORAL; Name: Physical Education (PE) programme; Assigned to Arm(s): Intervention Group
D: Arm Label: School-based intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Trial of Activity for Adolescent Girls (TAAG) | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Trial of Activity for Adolescent Girls (TAAG); Assigned to Arm(s): School-based intervention

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Efficacy of a Nursing Intervention in the Process of Becoming a Mother, in First-time Mothers
Brief Summary: Experimental study will determine the efficacy of nursing intervention named Maternal support to become first-time mothers based on the theory of Ramona Mercer. Sequential explanatory design will be used. It is a mixed design with approach quantitative and qualitative in order to obtain a better approach of the phenomen. The approach quantitative will be randomized controlled clinical trial. The qualitative analysis of the content will be done according to Bardin.


Options:
A: Arm Label: Maternal support to become mother; Type: EXPERIMENTAL; Interventions: Behavioral: Maternal support to become mother | Arm Label: Control group: usual Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Control Group: usual care | Intervention Type: BEHAVIORAL; Name: Maternal support to become mother; Assigned to Arm(s): Maternal support to become mother | Intervention Type: BEHAVIORAL; Name: Control Group: usual care; Assigned to Arm(s): Control group: usual Care
B: Arm Label: TSM Arm; Type: EXPERIMENTAL; Interventions: Other: Tarang Adolescence Education programme, Other: SEHER Intervention | Arm Label: SM Arm; Type: EXPERIMENTAL; Interventions: Other: Tarang Adolescence Education programme, Other: SEHER Intervention | Arm Label: Comparison Arm; Type: OTHER; Interventions: Other: Tarang Adolescence Education programme | Intervention Type: OTHER; Name: Tarang Adolescence Education programme; Assigned to Arm(s): Comparison Arm, SM Arm, TSM Arm | Intervention Type: OTHER; Name: SEHER Intervention; Assigned to Arm(s): SM Arm, TSM Arm
C: Arm Label: TSM arm; Type: EXPERIMENTAL; Interventions: Behavioral: SEHER Intervention delivered by TSM, Behavioral: Tarang AEP | Arm Label: SM arm; Type: EXPERIMENTAL; Interventions: Behavioral: SEHER Intervention delivered by SM, Behavioral: Tarang AEP | Arm Label: Comparison arm Tarang AEP; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Tarang AEP | Intervention Type: BEHAVIORAL; Name: SEHER Intervention delivered by TSM; Assigned to Arm(s): TSM arm | Intervention Type: BEHAVIORAL; Name: SEHER Intervention delivered by SM; Assigned to Arm(s): SM arm | Intervention Type: BEHAVIORAL; Name: Tarang AEP; Assigned to Arm(s): Comparison arm Tarang AEP, SM arm, TSM arm
D: Arm Label: Mothers and Babies Groups Home-Visitor; Type: EXPERIMENTAL; Interventions: Behavioral: Mothers and Babies Groups | Arm Label: Mothers and Babies Groups Clinician; Type: EXPERIMENTAL; Interventions: Behavioral: Mothers and Babies Groups | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Mothers and Babies Groups; Assigned to Arm(s): Mothers and Babies Groups Clinician, Mothers and Babies Groups Home-Visitor

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Prospective, Randomised, Crossover, Controlled, Feasibility Study to Assess the Efficacy of BurstDR Spinal Cord Stimulation (SCS) as a Treatment for Persistent AbdomiNal RefrActory VisCEral PAin Secondary to Chronic Pancreatitis: PANACEA Trial
Brief Summary: To evaluate the effectiveness of Burst DR stimulation as a treatment for persistent abdominal refractory visceral pain secondary to chronic pancreatitis. Abdominal pain is a main symptom in patients with chronic pancreatitis. Patients have a background constant pain with acute episodes needing admissions. Spinal cord stimulation (SCS) is a recognised treatment for neuropathic pain. This involves placing an electric wire in the spine and the use of electricity to manage the pain. This is a pacemaker for controlling pain. Burst DR stimulation delivers a wave form which mimics the way nerves conduct electrical signals, there are short bursts or spikes of stimulation followed by short periods of rest. The key aims and objectives of this study are to evaluate the efficacy of Burst DR SCS as a treatment for persistent pain secondary to chronic pancreatitis


Options:
A: Intervention Type: DEVICE; Name: Spinal Cord Stimulation; Assigned to Arm(s): N/A
B: Intervention Type: DRUG; Name: pregabalin; Assigned to Arm(s): N/A
C: Arm Label: EES on; Type: EXPERIMENTAL; Interventions: Device: EES on | Arm Label: EES off; Type: PLACEBO_COMPARATOR; Interventions: Device: EES off | Intervention Type: DEVICE; Name: EES on; Assigned to Arm(s): EES on | Intervention Type: DEVICE; Name: EES off; Assigned to Arm(s): EES off
D: Arm Label: Group A - active treatment; Type: EXPERIMENTAL; Interventions: Device: Spinal cord stimulation by implanted device. | Arm Label: Group B - conservative management; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Spinal cord stimulation by implanted device.; Assigned to Arm(s): Group A - active treatment

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Prospective, Randomised, Crossover, Controlled, Feasibility Study to Assess the Efficacy of BurstDR Spinal Cord Stimulation (SCS) as a Treatment for Persistent AbdomiNal RefrActory VisCEral PAin Secondary to Chronic Pancreatitis: PANACEA Trial
Brief Summary: To evaluate the effectiveness of Burst DR stimulation as a treatment for persistent abdominal refractory visceral pain secondary to chronic pancreatitis. Abdominal pain is a main symptom in patients with chronic pancreatitis. Patients have a background constant pain with acute episodes needing admissions. Spinal cord stimulation (SCS) is a recognised treatment for neuropathic pain. This involves placing an electric wire in the spine and the use of electricity to manage the pain. This is a pacemaker for controlling pain. Burst DR stimulation delivers a wave form which mimics the way nerves conduct electrical signals, there are short bursts or spikes of stimulation followed by short periods of rest. The key aims and objectives of this study are to evaluate the efficacy of Burst DR SCS as a treatment for persistent pain secondary to chronic pancreatitis


Options:
A: Arm Label: Active Lead (AL); Type: ACTIVE_COMPARATOR; Interventions: Device: Nevro Senza System (HF10 Therapy) | Arm Label: Sham Lead (SL); Type: SHAM_COMPARATOR; Interventions: Device: Nevro Senza System (HF10 Therapy) | Intervention Type: DEVICE; Name: Nevro Senza System (HF10 Therapy); Assigned to Arm(s): Active Lead (AL), Sham Lead (SL)
B: Arm Label: EES on; Type: EXPERIMENTAL; Interventions: Device: EES on | Arm Label: EES off; Type: PLACEBO_COMPARATOR; Interventions: Device: EES off | Intervention Type: DEVICE; Name: EES on; Assigned to Arm(s): EES on | Intervention Type: DEVICE; Name: EES off; Assigned to Arm(s): EES off
C: Arm Label: Sham; Type: SHAM_COMPARATOR; Interventions: Device: Sham | Arm Label: 1200 Hz; Type: EXPERIMENTAL; Interventions: Device: 1200 Hz | Arm Label: 3030 Hz; Type: EXPERIMENTAL; Interventions: Device: 3030 Hz | Arm Label: 5882 Hz; Type: EXPERIMENTAL; Interventions: Device: 5882 Hz | Intervention Type: DEVICE; Name: Sham; Assigned to Arm(s): Sham | Intervention Type: DEVICE; Name: 1200 Hz; Assigned to Arm(s): 1200 Hz | Intervention Type: DEVICE; Name: 3030 Hz; Assigned to Arm(s): 3030 Hz | Intervention Type: DEVICE; Name: 5882 Hz; Assigned to Arm(s): 5882 Hz
D: Arm Label: Group A - active treatment; Type: EXPERIMENTAL; Interventions: Device: Spinal cord stimulation by implanted device. | Arm Label: Group B - conservative management; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Spinal cord stimulation by implanted device.; Assigned to Arm(s): Group A - active treatment

Answer: D